INS and Hypoglycemia: Moreover, the consensus report highlights that the beneficial effects of these drugs are likely not outweighed by the risk of severe hypoglycemia or DKA, given the current availability of advanced AID systems able to effectively predict and prevent such adverse events through algorithm-based changes in insulin delivery [213].